SCHEMBL19224281

SCHEMBL19224281

FC(F)(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.50
▸ TAAR1 Q96RJ0 1/20 0.50
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ LMNA P02545 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CALM1 P0DP23 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ CES1 P23141 1/20 0.44
▸ FDPS P14324 1/20 0.43
▸ EPHX2 P34913 1/20 0.42
▸ TSHR P16473 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ TRPA1 O75762 2/20 0.41
▸ IDO1 P14902 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10633769 0.87 SLC6A2 (0.44) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL3438750 0.87 SLC6A2 (0.50) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL2008546 0.85 CYP1A2 (0.46) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL17288517 0.85 SLC6A2 (0.43) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL10159611 0.85 TSHR (0.46) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL3712396 0.85 TAAR1 (0.48) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL185769 0.82 SLC6A2 (0.50) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL29633636 0.81 TDP1 (0.44) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL11616310 0.81 SLC6A2 (0.40) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19
SCHEMBL5211703 0.80 SLC6A2 (0.48) SLC6A2TAAR1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170226054-A1 FLUORINE-BASED COMPOUND FOR BRANCHER, POLYMER USING SAME, AND POLYMER ELECTROLYTE MEMBRANE USING SAME LG CHEM, LTD. (KR) 2017-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226054-A1 FLUORINE-BASED COMPOUND FOR BRANCHER, POLYMER USING SAME, AND POLYMER ELECTROLYTE MEMBRANE USING SAME AFF4, AFF2, PFAS SLC6A2 690/4885TAAR1 1616/4885CYP1A2 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback